FC
Foresite Capital Management III, LLC
Concentrated strategyQuality / disciplined sizingLong-term holder
Total reported value
$37.9M
Reporting period: 2022-09-30 · Number of holdings: 4
Foresite Capital Management III, LLC disclosed 4 holdings in its latest 13F filing for the period ending 2022-09-30, with total reported value of $37.9M and a quarterly turnover rate of 0.0%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 0
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 8
- Sizing Uniformity
- 96.03
Recent moves
No holding changes this quarter
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | Stock-Other | 36.44% | — | — | |
| 2 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 29.98% | — | — | |
| 3 | NTRA | Natera INC | Stock-Healthcare | 18.41% | — | — | |
| 4 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 15.17% | — | — |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2022-09-30 | 4 | $37.9M | 0 | |
| 2022-06-30 | 4 | $27.6M | 0 | |
| 2022-03-31 | 4 | $32.8M | 0 | |
| 2021-12-31 | 4 | $39.5M | 0 | |
| 2021-09-30 | 6 | $72.1M | 0 | |
| 2021-06-30 | 8 | $94.3M | 100 | |
| 2021-03-31 | 8 | $113.9M | 71 | |
| 2020-12-31 | 8 | $86.0M | 78 | |
| 2020-09-30 | 10 | $134.3M | 83 | |
| 2020-06-30 | 8 | $112.5M | 85 | |
| 2020-03-31 | 9 | $62.8M | 100 | |
| 2019-12-31 | 10 | $178.4M | 80 | |
| 2019-09-30 | 14 | $261.9M | 24 | |
| 2019-06-30 | 18 | $304.9M | 29 | |
| 2019-03-31 | 19 | $384.2M | 33 | |
| 2018-12-31 | 22 | $304.5M | 48 | |
| 2018-09-30 | 24 | $453.2M | 19 | |
| 2018-06-30 | 24 | $464.4M | 27 | |
| 2018-03-31 | 24 | $458.8M | 35 | |
| 2017-12-31 | 17 | $356.3M | 28 | |
| 2017-09-30 | 20 | $363.1M | 43 | |
| 2017-06-30 | 26 | $306.1M | 53 | |
| 2017-03-31 | 25 | $260.5M | 34 | |
| 2016-12-31 | 20 | $230.1M | 54 | |
| 2016-09-30 | 17 | $214.0M | 64 | |
| 2016-06-30 | 18 | $145.7M | 57 | |
| 2016-03-31 | 23 | $129.2M | 62 | |
| 2015-12-31 | 19 | $112.8M | 0 |
Holding changes this quarter
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
FAQ
What is Foresite Capital Management III, LLC and what type of investor is it?
Foresite Capital Management III, LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2022-09-30), the firm manages a tracked equity portfolio valued at approximately $37.9M, spread across 4 disclosed positions.
What are Foresite Capital Management III, LLC's largest equity positions?
Based on the latest 13F filing, Foresite Capital Management III, LLC's top holdings by market value are:
1. Ascendis Pharma A/S (ASND) — $13.8M (36.4%)
2. Verona Pharma PLC - Adr (VRNA) — $11.4M (30.0%)
3. Natera INC (NTRA) — $7.0M (18.4%)
4. Cymabay Therapeutics INC (CBAYUSD) — $5.7M (15.2%)
What changes did Foresite Capital Management III, LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Foresite Capital Management III, LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Foresite Capital Management III, LLC focus on?
Foresite Capital Management III, LLC is concentrated in the following sectors based on its current disclosed equity portfolio:
• Health Care: 100.0%